Llwytho...

Inhibitor of Apoptosis (IAP) proteins as drug targets for the treatment of cancer

Three companies, Genentech, Aegera Therapeutics/Human Genome Sciences, and Novartis, have commenced phase 1 clinical trials of inhibitor of apoptosis (IAP) antagonist ‘Smac mimetic’ compounds for the treatment of cancer. These trials represent the culmination of a line of research that commenced wit...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awdur: Vaux, David L
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Biology Reports Ltd 2009
Pynciau:
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC2948278/
https://ncbi.nlm.nih.gov/pubmed/20948609
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3410/B1-79
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!